Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Braxia Scientific Corp (OP: BRAXF ) 0.0031 UNCHANGED Streaming Delayed Price Updated: 3:00 PM EST, Nov 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Braxia Scientific Corp < Previous 1 2 Next > I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience August 13, 2024 Via Benzinga Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More March 01, 2024 Via Benzinga Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream' February 29, 2024 Via Benzinga Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More December 11, 2023 John Lennon Remembered 43 Years After His Murder In New York, Psychedelic Adventures & Enduring Legacy Via Benzinga Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company? December 04, 2023 Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC Pink: BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30,... Via Benzinga Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More September 05, 2023 Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Via Benzinga Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss August 31, 2023 Braxia Scientific Corp. Via Benzinga Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More June 13, 2023 Science Conference In Dubai, UAE Hosts Discussion On Psychedelics Research Via Benzinga BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue June 09, 2023 Psychedelics biotech BetterLife Pharma (OTCQB: BETRF) announced its non-hallucinogenic LSD derivative, BETR-001, is progressing through IND-enabling studies toward expected clinical studies targeting... Via Benzinga Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More March 20, 2023 Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered Via Benzinga Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal March 16, 2023 Irwin Naturals Inc. Via Benzinga Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More March 07, 2023 Psychedelics Bills Around The Country: 9 New Proposals, Several Passes, Several Fails And A Successful Local Decriminalization Throughout the 2023 session, numerous discussions have been... Via Benzinga Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals March 02, 2023 Research and telemedicine company Braxia Scientific Corp. (OTC: BRAXF) has filed its financial statements for the third quarter ended Dec. Via Benzinga Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA February 21, 2023 Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was... Via Benzinga Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics January 27, 2023 Irwin Naturals Inc. Via Benzinga 6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements January 10, 2023 Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space. Via Benzinga Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project December 06, 2022 Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... Via Benzinga Braxia Scientific Q2 2023 Financial Results: Health Clinic Ketamine Treatments Increases 34.5% YoY December 01, 2022 Braxia Scientific Corp., (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and... Via Benzinga Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More October 07, 2022 Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy Via Benzinga Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option October 05, 2022 Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S. Via Benzinga Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here September 13, 2022 The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions... Via Benzinga 4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed August 30, 2022 Field Trip (NASDAQ: FTRP), Wesana (OTCQB: WSNAF), Braxia (OTC: BRAXF) and Via Benzinga Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida August 03, 2022 A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp. Via Benzinga Braxia Scientific Fiscal 2022 Revenue Grows 47.5% YoY, What About Net Loss? August 01, 2022 Braxia Scientific Corp. (OTCPK:BRAXF) (CSE:RAX) (FWB:4960) recorded revenue of $1.49 million for the fiscal 2022 year ended March 31, 2022 compared with revenue of $1.008 million for the year ended... Via Benzinga Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments June 16, 2022 For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment. Via Benzinga Braxia Opens New Clinic in Ontario, Facilitating Further Access To Ketamine And Psilocybin Treatments June 15, 2022 Braxia Scientific Corp. Via Benzinga These 18 Clinical Trials Could Shape The Future Of The Psychedelics Industry June 02, 2022 In the nascent industry of medical psychedelics, drug development is the name of the game. This subset of biotech, poised to become a $100 billion industry according to Canaccord Genuity, bases its... Via Benzinga Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction October 04, 2021 The Week In Psychedelics: Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
